|
HS Code |
727025 |
| name | (S)-Leucine |
| IUPAC_name | (2S)-2-amino-4-methylpentanoic acid |
| molecular_formula | C6H13NO2 |
| molar_mass | 131.17 g/mol |
| CAS_number | 61-90-5 |
| appearance | White crystalline powder |
| melting_point | 293 °C (decomposes) |
| solubility_in_water | 22.4 g/L (20 °C) |
| optical_rotation | [α]D20 +15.6° (c=2 in 6N HCl) |
| pKa1 | 2.33 (carboxyl group) |
| pKa2 | 9.74 (amino group) |
| chirality | S-configuration |
As an accredited (S)-Leucine factory, we enforce strict quality protocols—every batch undergoes rigorous testing to ensure consistent efficacy and safety standards.
| Packing | (S)-Leucine is packaged in a sealed, amber glass bottle containing 100 grams, labeled with chemical details, hazard symbols, and batch number. |
| Shipping | (S)-Leucine is shipped in tightly sealed containers to prevent contamination and degradation. The product is packaged according to standard chemical safety regulations, typically at ambient temperature, and clearly labeled for laboratory use. Ensure compliance with local and international regulations regarding the transportation and handling of chemicals. |
| Storage | (S)-Leucine should be stored in a tightly closed container, in a cool, dry, and well-ventilated area. Protect it from moisture, light, and incompatible substances such as strong oxidizing agents. Ideally, it should be kept at room temperature (15–25°C). Proper storage ensures the stability and prevents deterioration or contamination of the compound. |
Applications of (S)-Leucine in Industrial ManufacturingAs a leading manufacturer, we supply (S)-Leucine for various industrial sectors that rely on stringent compliance, precise formulation protocols, and advanced production techniques. The following sections highlight major downstream applications based on current market demands and validated manufacturing practices. 1. Pharmaceutical API Synthesis(S)-Leucine serves as a key chiral intermediate and peptide building block in the synthesis of active pharmaceutical ingredients (APIs), particularly for peptide-based drugs and L-amino acid formulations. Manufacturers integrate this material to achieve high optical purity and consistent molecular structure, directly influencing efficacy and safety profiles. Accurate dosing and validation against pharmacopeial standards are required. Production strictly tracks raw material lots and integrates in-line quality control at each peptide elongation and purification step. The final APIs proceed to formulation or direct export to finished drug processors. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
2. Medical Nutrition and Clinical Parenteral SolutionsHigh-purity (S)-Leucine is used in compounding medical nutrition solutions, including parenteral (intravenous) amino acid infusions for hospital and outpatient therapy. The product must meet stringent standards to avoid pyrogenic and microbiological contaminants, with consistent batch-to-batch assay results. Blending accuracy and traceability are controlled under ISO and GMP procedures. Downstream operations require real-time mixture monitoring, filtration, and aseptic packaging to comply with patient-use regulations. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
3. Biotech Fermentation and Cell Culture Media(S)-Leucine acts as a critical component in the preparation of chemically defined and semi-defined fermentation media, supporting production of recombinant proteins, monoclonal antibodies, and industrial enzymes. Its purity and isomeric specification directly influence cell viability, productivity, and downstream purification yield. Process engineers precisely weigh and blend the material into large-scale fermenters or automated media preparation systems, tracking lot data for batch release compliance. Continuous monitoring ensures consistent nutrient delivery throughout cell culture or microbial fermentation cycles. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
4. Food Additive and Functional Ingredient BlendsFood processors use (S)-Leucine to fortify protein powders, dietary supplements, and specialized food additives, especially in clinical and sports nutrition markets. Compliance focuses on purity, trace allergen controls, and adherence to food-grade residual solvent and heavy metal limits. The material often blends with other essential branched-chain amino acids in dry blend or wet granulation lines equipped with near-infrared (NIR) or HPLC assay verification for uniformity and food safety management. Finished lots receive rapid micro and allergen screen prior to release. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
5. Animal Feed and Veterinary Nutrition PremixesThe animal health industry utilizes (S)-Leucine to supplement compound feeds and veterinary premixes, addressing amino acid balance in high-value livestock and aquaculture. Feed manufacturers require accurate isomer and purity determination to align with national and international safety standards, using validated blending and pelleting procedures. Attention to homogeneity, heat resistance, and interaction with other micro-nutrients is critical for downstream product stability and animal performance. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
6. Biodegradable Polymer and Specialty Resin ManufacturingSpecialty polymer producers incorporate (S)-Leucine as a functionalized monomer or chiral auxiliary in the synthesis of biodegradable polyesters and bio-based thermoplastics. The process ensures molecular uniformity and maintains chirality to influence the crystallinity and mechanical properties of the final polymer. The material introduction timing and purity impact downstream extrusion or casting and final bioplastic functional properties. Analytical control verifies monomer conversion rate and environmental safety compliance. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
|
Competitive (S)-Leucine prices that fit your budget—flexible terms and customized quotes for every order.
For samples, pricing, or more information, please call us at +8615371019725 or mail to admin@sinochem-nanjing.com.
We will respond to you as soon as possible.
Tel: +8615371019725
Email: admin@sinochem-nanjing.com
Flexible payment, competitive price, premium service - Inquire now!
Our focus on manufacturing (S)-Leucine rises from years of refinement in controlled fermentation. We take the raw carbon source and build up each batch through a process that has seen tight troubleshooting and plenty of hours logged on the line. Small changes in feeding schedule and nutrient choice shift the final profile of the amino acid, especially when the target is the L-isomer—the only useful chirality for biological manufacturing, cell culture media, and nutritional blends.
Our (S)-Leucine, chemically known as L-leucine or (S)-2-amino-4-methylpentanoic acid, finds its use across several demanding sectors: biopharma, food fortification, and nutritional formulations. Each sector brings its own challenge, but the underlying need always looks the same—a clean, consistent, and traceable source. In our facility, stainless fermenters are rigged for control, followed by multi-step filtration and a purification train guided by both in-process sampling and experienced hands.
Over decades of combined manufacturing and analytical experience, we have put together a line where human intervention matters as much as the process. Operators rely on both digital readouts and hands-on inspection. They cross-check by smell, crystallinity, and flow properties. We have learned the hard way that (S)-Leucine reaches its peak function only after critical checks—not just at specification endpoints, but at several points throughout drying, milling, and packing.
Customers using (S)-Leucine ask about a lot more than purity. Modern chromatography can push racemic contamination down below 0.5%. For researchers and nutrition companies, optical rotation is still the sharpest proof of enantiomeric identity—the reason why simple purity alone doesn’t capture product integrity. Our analytical team built our workflow around this fact. At scale, even micro-impurities of D-isomer or breakdown products can accumulate trouble: off-tastes, unpredictable reactivity, or subtle shifts in growth profiles for cell-based systems. We invest not just in HPLC or polarimetry, but also in regular reviewing of raw material suppliers to anticipate any drift in precursor substances.
Food safety standards lean heavily toward traceability, especially for amino acids blending into clinical nutrition. Our batches integrate lot-level origin data and everything channeled through the plant—from fermentation nutrient grades to cleaning agent residues. This isn’t just compliance, but something tangible: customers downstream can request full analytic traces if end-users challenge any result. In more than one product launch, this kind of rigor has made the difference between a seamless rollout and disruptive recalls.
(S)-Leucine also finds steady application in animal health and feed industries, but the strictest scrutiny shows up in cell culture media manufacturing. Every time a new bioprocess comes online—whether for therapeutic protein or cultured meat—a fresh round of component testing gets underway. Protein engineers and process scientists send detailed inquiries down the supply chain, keen to spot hidden excipients or lot-to-lot inconsistencies. Our plant has adapted over time, answering these pressures with transparent production records and ready release of full specification sheets with each consignment.
There are plenty of suppliers and consolidators offering (S)-Leucine in the market. One thing that stands out when buying directly from us is not just price or speed, but the removal of those gray zones where documentation or communication can slip. We maintain a direct link: our technical and QA leads answer those very specific questions that come out of process design or scale-up meetings. From firsthand experience, the difference between a standard offering and one tweaked for a unique process window can make or break a bioreactor campaign or product launch. Direct feedback from process partners reaches our operations team on the ground, which gives us a real reason to refine both our drying process and our physical attribute benchmarks.
Take, for example, a pharma group validating their media supplement protocol. Initial formulations would fail to dissolve cleanly below the target temperature. It wasn’t a chemistry problem—but a subtle physical property issue tied to particle size and moisture. Our team tightened our final drying window and altered our milling mesh. Reporting this adjustment in real time to our customer bridged the gap between spec and solution. This is how years of building from small batch to ton-scale production have shaped both our troubleshooting and our open-door policy on feedback.
We understand how a small variation in particle size or bulk density influences how (S)-Leucine performs in a final blend. In high-throughput tableting, a fine, dustlike product may create fluidity and compaction headaches. Some partners in sports nutrition want a granular flow—anything too fine becomes electrostatically charged and cakes up on the line. Another set working in contract manufacturing asks the opposite: the smallest possible particles to improve solubility and mixing with other amino acids.
Years spent refining milling and drying steps have taught our team plenty about nuance. The way humidity lingers after tray drying, or the way a mesh setting intersects with ambient temperature, changes everything about the final appearance. Each run, we check microcrystalline texture, residue after drying, and measure both true density and “tap” density. At scale, the economics of each step matter, but preventing a downstream process stoppage from caking or bridging matters more.
We supply as fine powder, crystalline granules, or customized blends. Each variant targets the real need on the line. Sports supplement companies working with single-lot runs look for rapid wetting and no off-putting flavor—whereas pharma partners demand the highest possible solubility and consistently negative test for microbial residues. We document every parameter: moisture, pH in suspension, ash levels, even measure possible residual solvents with headspace GC, despite these being far below regulatory limits in any latest batch.
We set up our plant for direct process traceability, so each package and bulk lot links straight to in-house analytical endpoints. Every packaging run keeps a retain sample, not as a need for secondary verification, but as a living record—should a customer ever request a root-cause analysis or secondary check. (S)-Leucine leaves our facility with a paper trail, checked both by our production teams and third-party auditors during annual markups.
Our lab checks each finished batch for purity, enantiomeric excess, heavy metals, and pesticide screen. These are not optional steps but part of daily rhythm. Sometimes a batch comes off the line that doesn’t quite hit a target metric: maybe moisture strays half a percent, or the alpha crystal form shows a slight change under microscopy. In those cases, we halt shipment and rerun until the trend reverses. There’s no substitute for this discipline. Many times, raw materials markets shift in price or quality, but our standards stay put.
Our customers—particularly in regulated industries—rightly demand proof. Our team answers not just with a certificate, but explains the process changes, reasons for each adjustment, and implications. Over years of meeting audits and fielding requests, we’ve carved out a reputation for real-time transparency. This has kept our product line in regulatory compliance and protected partner brands from quality drift.
The two main isomers of leucine—L-form and D-form—cannot serve the same purpose. In human and animal nutrition, only the (S)-enantiomer (the L-form) participates effectively in protein synthesis and metabolism. A batch cut with the wrong stereochemistry—intentional or not—changes everything. Our methods achieve over 99.8% optical purity, surpassing many targets for cell and tissue engineering.
Compared to generic “leucine” or mixed-source products, our (S)-Leucine stands apart because we only run a single-enantiomer output from non-animal fermentation at cGMP-level facilities. Many leucine brands on the market blend material from hydrolyzed feathers, wool, or hair, which risks introducing allergens and variability—something our customers in parenteral nutrition and cosmetics refuse to tolerate.
We track not just proteinogenic purity, but trace contaminant classes known to creep in during fermentation: endotoxins, peptone residues, off-odor side products. Our heavy metal screen sweeps for arsenic, cadmium, and mercury, which crop up in lesser-regulated feeds or recycled hydrolysates. Fats and trace pesticide residues feature in our screen, not because regulators always require these but because our experience says the best precaution is to monitor before a problem can surface at market.
Since launch, (S)-Leucine has become a backbone for partners in four continents. Cell culture specialists report less batch-to-batch variability and fewer unexplained impurities compared to their imports from smaller, lower-oversight facilities. In the sports nutrition world, brand formulators call out improved flavor and quicker dissolution—two properties traced back to our quality control at the drying phase.
In field trials, livestock nutritionists noted improved feed consistency and measured early signs of better muscle gain at equivalent protein levels, validating benefits as measured not just in the lab, but at scale. Clients building new clinical nutrition lines use our process documentation to smooth direct import clearance, shortening timelines and supporting audit cycles for WHO and PIC/S regions. None of this happens by default; each advance shows up only through hands-on, open channels between our technical team and customer process designers. We have learned from years covering action through the entire supply chain that batch interruptions often trace back to the finest points—a minor difference in hydration or mixing rate becomes a cascade.
Over the years, we’ve seen every kind of challenge crop up on the line and in the market. Contamination with off-isomer can ruin an entire manufacturing schedule—something most visible in processes making bioreactor-grown products, where a single deviation in amino acid chirality slams cell productivity. We pulled material from the market before, losing real money but protecting brand reputation and customer supply chains.
In another case, a shipment took on excess moisture en route to a hot, humid region, compromising both caking and solubility. We stepped up to overhaul both packaging materials and logistics coordination, ensuring downstream partners could keep pace with product launches in even the most challenging climates.
Several smaller nutrition companies ran into trouble scaling up, lacking on-site quality control and finding wide variability in particle size and taste between batches sourced from traders. We addressed this by offering tailored production runs and in-person troubleshooting, including detailed physical screening, to stabilize their own mixing and packaging lines. Changes here made a visible difference not only in product runnability but, more importantly, in customer complaints and returns seen by our partners.
Direct dialogue with formulators and engineers keeps our (S)-Leucine line from stagnating. Feedback on everything from solubility at varying pH to off-flavors in premixes drives our development cycle. In the last year, steady requests for lower-residue, finer mesh powder led us to build out a micronization line. This line is run by operators who have watched how particle statistics line up with process downtime or blending issues.
We keep an open channel not just to large firms, but also small specialists and laboratories who care about experiment repeatability. Years ago, a single case of spotting after tableting led our team to alter the final drying cycle, finding that trace water content influenced both appearance and shelf-life. That change became permanent, improving the whole line for everyone who relies on color and stability in finished products.
Pressure to improve environmental responsibility grows year by year. We shifted to non-animal fermentation not only to satisfy regulatory needs, but also to cut palatability fears and support global market entry in regions wary of animal-derived materials. Sourcing fermentation nutrients involves weighing availability, cost, and traceability. Over time, this meant building deeper links with primary bulk suppliers and working through audits on both contamination risk and sustainability.
Onsite, our energy and water audits seek continuous reduction in use per kg of amino acid output. We recover and recycle our rinse water, invest in closed cooling, and have replaced several cleaning agents with food-contact-safe and lower-residue alternatives. Our waste biomass exits as feed for agricultural partners, closing the loop for both cost and environmental scrutiny.
Shipping choices follow the product through to the last mile—each new climate, regulatory shift, or consumer concern pushes us to revisit the packaging materials, tamper controls, and documentation. Experience shows that preempting questions wins trust: every customs or port query becomes a test of our records, so we build compliance not as an add-on but as a matter of routine.
Global demand for (S)-Leucine continues to rise, especially in engineered foods, next-generation biologics manufacturing, and medical nutrition. We have responded not with generic promises, but with practical steps: adding capacity, doubling down on quality checkpoints, and training technical staff to recognize both laboratory and plant-floor deviations before they reach the customer.
More partners count on us for support in troubleshooting, specification tuning, and smooth scaling as demand shifts seasonally or as new formulations hit their market. Each inquiry adds to a practical pool of know-how. Problems rarely fit a template—they show up as edge cases, unexpected feedback, or the subtle effects of scale. In supporting our customers abroad and at home, our team learns, adapts, and puts better product back on the line. We treat every batch and every new partner as an opportunity to refine, using evidence and straightforward talk backed by years in the plant, not guesswork or marketing gloss.
(S)-Leucine means more than a chemical. It represents a direct outcome of hard-won expertise, strict discipline, and a firm handshake between production know-how and market need. By holding onto that approach, we keep each gram reliable and ready—no matter the application or outcome that follows.